USP13 and ovarian serous cystadenocarcinoma: Analysis of TCGA data indicates that USP13 is rarely mutated, but the USP13 gene is highly amplified (19.5% Amp) or gained (58.5 % Gain) in human ovarian serous cystadenocarcinoma (Fig. 1A).